| Anna Wilkins |
Prediction of the efficacy and side effects of hypofractionated radiotherapy in prostate cancer. |
2013-2019 |
Co-primary supervisor: E Hall
Co-primary supervisor: D Dearnaley (RMH/ICR)
|
| Indrani Bhattacharya |
Optimising trial methodologies to maximise trial efficiencies: a case study in breast cancer radiotherapy trials |
2016-2019 |
Primary supervisor: A Kirby (RMH/ICR)
Associate supervisor(s): J Bliss, J Haviland
|
| Holly Tovey |
Identification of biomarkers to predict response for emerging therapeutic agents for triple negative breast cancer |
2018- |
Primary supervisor: M Cheang
Associate supervisor(s): Anita Grigoriadis (KCL), Andrew Tutt (ICR/Guy's)
|
| Harry Parr |
Dynamic prediction statistical models to characterise localised prostate cancer prognosis |
2018- |
Primary supervisor: E Hall
Associate supervisor(s): N Porta, A Tree, D Dearnaley (RMH/ICR)
|
| Lara Phillips |
Efficient assessment of toxicity related outcomes in pelvic radiotherapy trials |
2020- |
Primary supervisor: E Hall
|
| Zhulin Yin |
Development and Implementation of Efficient Adaptive Designs in Early Phase Oncology Trials for Novel Agents |
2020- |
Primary supervisor: C Yap
Associate supervisor(s): A Mander (Cardiff University), H Zheng (Cambridge), J de Bono (ICR), J Bliss
|
| Xixuan Zhu |
COUNTERPOINT: An artificial intelligence-based clinical calculator, weaving tumour genomics, microenvironment and clinicopathological data, to predict disease outcomes in women with triple negative breast cancer |
2021- |
Primary supervisor: M Cheang
Associate supervisor(s): C Yap
|
| Szeyi Ng |
Enabling better reporting of outcomes for breast cancer radiotherapy trials |
2021- |
Primary supervisor(s): J Bliss, C Coles (Cambridge)
Associate supervisor(s): J Haviland, I Bhattacharya (Cambridge)
|
| Nivetha Sridharan |
Maximizing the use of imaging in clinical trials |
2021- |
Primary supervisor: J O'Connor (ICR)
Associate supervisor(s): N Porta, DM Koh (RMH/ICR)
|
| Georgiana Synesi |
Increasing representation of under-served groups in randomised oncology trials |
2022- |
Primary supervisor: E Hall
Associate supervisor(s): L Kilburn, R Lewis
|
| Emily Alger |
Incorporating Patient-reported Outcomes (PROs) in Early Phase Dose-finding Cancer Trials |
2022- |
Primary supervisor: C Yap
Associate supervisor(s): A Minchom (RMH/ICR), J de Bono (ICR)
|